{"id":4732,"date":"2023-10-02T21:34:55","date_gmt":"2023-10-02T12:34:55","guid":{"rendered":"https:\/\/www.aureo.co.jp\/?p=4732"},"modified":"2023-10-03T17:02:44","modified_gmt":"2023-10-03T08:02:44","slug":"i364284","status":"publish","type":"post","link":"https:\/\/www.aureo.co.jp\/en\/patent\/i364284\/","title":{"rendered":"Bio-healing agent – Taiwan (Taiwan Patent No. I364284)"},"content":{"rendered":"

<\/p>\n

Patent Details<\/p>\n

\n
\n
\n
Patent No.<\/div>\n<\/dt>\n
Invention No. I364284<\/dd>\n<\/dl>\n
\n
\n
Registration Date<\/div>\n<\/dt>\n
May 21, 2012<\/dd>\n<\/dl>\n<\/div>\n

Currently, in Japan, Europe (UK, France, Germany), China, Hong Kong, Taiwan, and Thailand, Aureobasidium (black yeast) culture medium (hereafter referred to as “Aureo culture medium”) has been recognized to reduce the side effects of anticancer drugs and to promote the healing of erythema caused by burn wounds.<\/p>\n

Furthermore, in Taiwan, the combination of Aureobasidium culture solution and EF lactobacilli was also registered to improve the pathogenesis of leukemia.<\/p>\n","protected":false},"excerpt":{"rendered":"

Patent Details Patent No. Invention No. I364284 Registration Date May 21, 2012 Currently, in Japan, Europe (UK, France, Germany), China, Hong Kong, Taiwan, and Thailand, Aureobasidium (black yeast) culture medium (hereafter referred to as “Aureo culture medium”) has been recognized<\/p>\n","protected":false},"author":6,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_locale":"en_US","_original_post":"https:\/\/www.aureo.co.jp\/?p=4158","footnotes":""},"categories":[9],"tags":[],"class_list":["post-4732","post","type-post","status-publish","format-standard","hentry","category-patent","en-US"],"acf":[],"aioseo_notices":[],"aioseo_head":"\n\t\t\n\t\n\t\n\t\n\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t